Max Colao, MBA, is the founding Chief Executive Officer of OncoVerity and brings over 30 years of biotechnology leadership experience. Prior to founding OncoVerity, he served as Chief Commercial Officer at Aurinia, where he built and led the commercial organization through a successful launch. He previously held senior leadership roles at Alexion, where he led U.S. commercial operations and drove multiple rare disease therapy launches. Max also spent two decades at Amgen in senior commercial roles, launching therapies across hematology, oncology, and autoimmune disorders, and playing a key role in Amgen’s evolution from a small biotech into a pharmaceutical powerhouse.